IP Library Granted Patent US 8,653,307
Granted Patent B2
US 8,653,307 · App. 13/485,835 · Granted Feb 18, 2014

Liphagal enantiomers and their derivatives and precursors, and enantioselective methods of making the same

Inventors: Brian M Stoltz (San Marino, CA); Ryan McFadden (Foster City, CA); Scott C. Virgil (Pasadena, CA); Helene Kolding (Lyngby, DK); Jennifer L Alleva (Princeton, NJ); Joshua J Day (Fort Collins, CO)
Assignee: California Institute of Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,653,307
App. No.
13/485,835
Granted
Feb 18, 2014
Kind
B2
Abstract

Enantioenriched compositions of liphagal and its derivatives and precursors include more than 50 mol % of a first enantiomer based on the total amount of a first and a second enantiomer. A method of making an enantioenriched composition includes catalytic enantioselective alkylation, ring expansion, and intramolecular aryne cyclization.

Claims (23)

1. A method for preparing a compound of Formula 17A:

comprising treating a compound of Formula 17B:

under [2+2] photocycloaddition conditions with a compound represented by the Formula (I):

R 29 R 30   (1)

wherein:

R 8 -R 16 and R 24 are independently selected from hydrogen, alkyl group and carbonyl group;

R 21 and R 28 are hydrogen; and

R 29 and R 30 are independently hydrogen or trialkylsilyl group.

2. A method for preparing a compound of Formula 18A:

comprising treating a compound of Formula 18B:

under [2+2] photocycloaddition conditions with a compound represented by the Formula (I):

R 29 R 30   (1)

wherein:

R 8 -R 16 and R 24 are independently hydrogen or an alkyl group;

R 21 and R 28 are hydrogen; and

R 29 and R 30 are independently hydrogen or trialkylsilyl group.

3. The method of claim 1 or 2 , wherein R 24 is hydrogen.

4. The method of claim 1 or 2 , wherein the compound of Formula (I) is trimethylsilyl acetylene.

5. The method of claim 1 or 2 , wherein the photocycloaddition conditions comprise UV radiation.

6. The method of claim 1 or 2 , wherein the UV radiation comprises UVB radiation.

7. The method of claim 1 or 2 , wherein the photocycloaddition conditions comprise a solvent.

8. The method of claim 7 , wherein the solvent comprises acetone.

9. The method of claim 1 or 2 , wherein the method further comprises treating a compound of Formula 17A or 17B with a Lewis acid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2012
From: STOLTZ, BRIAN M.; MCFADDEN, RYAN; VIRGIL, SCOTT C.; KOLDING, HELENE; ALLEVA, JENNIFER L.; DAY, JOSHUA J.
To: CALIFORNIA INSTITUTE OF TECHNOLOGY
Reel/Frame 029092/0587 →
CONFIRMATORY LICENSE Recorded Oct 1, 2012
From: CALIFORNIA INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029060/0259 →
Continuity (2)
Provisional Application 61491631 · May 31, 2011
Related Publication 20130023676A1 · Jan 24, 2013